Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 66 entries
Sorted by: Best Match Show Resources per page
Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience.

Clinical genitourinary cancer

Rodin D, Drumm M, Clayman R, Buscariollo DL, Galland-Girodet S, Eidelman A, Feldman AS, Dahl DM, McGovern FJ, Olumi AF, Niemierko A, Shipley WU, Zietman AL, Efstathiou JA.
PMID: 28864223
Clin Genitourin Cancer. 2017 Aug 03; doi: 10.1016/j.clgc.2017.07.026. Epub 2017 Aug 03.

BACKGROUND: Salvage radiotherapy (SRT) has been successfully used for recurrent prostate cancer after radical prostatectomy; however, the optimal timing of SRT remains controversial. Our objective was to identify the risk factors for disease progression after SRT, with a focus...

Cite
Rodin D, Drumm M, Clayman R, et al. Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience. Clin Genitourin Cancer. 2017;doi: 10.1016/j.clgc.2017.07.026.
Rodin, D., Drumm, M., Clayman, R., Buscariollo, D. L., Galland-Girodet, S., Eidelman, A., Feldman, A. S., Dahl, D. M., McGovern, F. J., Olumi, A. F., Niemierko, A., Shipley, W. U., Zietman, A. L., & Efstathiou, J. A. (2017). Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience. Clinical genitourinary cancer, . https://doi.org/10.1016/j.clgc.2017.07.026
Rodin, Danielle, et al. "Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience." Clinical genitourinary cancer vol. (2017). doi: https://doi.org/10.1016/j.clgc.2017.07.026
Rodin D, Drumm M, Clayman R, Buscariollo DL, Galland-Girodet S, Eidelman A, Feldman AS, Dahl DM, McGovern FJ, Olumi AF, Niemierko A, Shipley WU, Zietman AL, Efstathiou JA. Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience. Clin Genitourin Cancer. 2017 Aug 03; doi: 10.1016/j.clgc.2017.07.026. Epub 2017 Aug 03. PMID: 28864223.
Copy Download .nbib Format: NLM
The Red Journal's Top Downloads of 2015.

International journal of radiation oncology, biology, physics

Zietman AL.
PMID: 27302501
Int J Radiat Oncol Biol Phys. 2016 Jul 01;95(3):861-863. doi: 10.1016/j.ijrobp.2016.02.047.

No abstract available.

Cite
Zietman AL. The Red Journal's Top Downloads of 2015. Int J Radiat Oncol Biol Phys. 2016;95(3):861-863doi: 10.1016/j.ijrobp.2016.02.047.
Zietman, A. L. (2016). The Red Journal's Top Downloads of 2015. International journal of radiation oncology, biology, physics, 95(3), 861-863. https://doi.org/10.1016/j.ijrobp.2016.02.047
Zietman, Anthony L. "The Red Journal's Top Downloads of 2015." International journal of radiation oncology, biology, physics vol. 95,3 (2016): 861-863. doi: https://doi.org/10.1016/j.ijrobp.2016.02.047
Zietman AL. The Red Journal's Top Downloads of 2015. Int J Radiat Oncol Biol Phys. 2016 Jul 01;95(3):861-863. doi: 10.1016/j.ijrobp.2016.02.047. PMID: 27302501.
Copy Download .nbib Format: NLM
In Reply to Samaratunga et al.

International journal of radiation oncology, biology, physics

Zietman A, Smith J, Klein E, Droller M, Dasgupta P, Catto J.
PMID: 27869088
Int J Radiat Oncol Biol Phys. 2016 Dec 01;96(5):1127-1128. doi: 10.1016/j.ijrobp.2016.08.027.

No abstract available.

Cite
Zietman A, Smith J, Klein E, et al. In Reply to Samaratunga et al. Int J Radiat Oncol Biol Phys. 2016;96(5):1127-1128doi: 10.1016/j.ijrobp.2016.08.027.
Zietman, A., Smith, J., Klein, E., Droller, M., Dasgupta, P., & Catto, J. (2016). In Reply to Samaratunga et al. International journal of radiation oncology, biology, physics, 96(5), 1127-1128. https://doi.org/10.1016/j.ijrobp.2016.08.027
Zietman, Anthony, et al. "In Reply to Samaratunga et al." International journal of radiation oncology, biology, physics vol. 96,5 (2016): 1127-1128. doi: https://doi.org/10.1016/j.ijrobp.2016.08.027
Zietman A, Smith J, Klein E, Droller M, Dasgupta P, Catto J. In Reply to Samaratunga et al. Int J Radiat Oncol Biol Phys. 2016 Dec 01;96(5):1127-1128. doi: 10.1016/j.ijrobp.2016.08.027. PMID: 27869088.
Copy Download .nbib Format: NLM
Randomized Trials in Loco-Regionally Confined Prostate Cancer: Past, Present, and Future.

Seminars in radiation oncology

Zietman AL, Shipley WU.
PMID: 10717072
Semin Radiat Oncol. 1993 Jul;3(3):210-220. doi: 10.1053/SRAO00300210.

Over the last 30 years, a vast literature has been published on the available therapeutic approaches for loco-regionally confined prostate cancer. However, it is remarkable how few well designed and well conducted randomized trials have set out to compare...

Cite
Zietman AL, Shipley WU. Randomized Trials in Loco-Regionally Confined Prostate Cancer: Past, Present, and Future. Semin Radiat Oncol. 1993;3(3):210-220doi: 10.1053/SRAO00300210.
Zietman, A. L., & Shipley, W. U. (1993). Randomized Trials in Loco-Regionally Confined Prostate Cancer: Past, Present, and Future. Seminars in radiation oncology, 3(3), 210-220. https://doi.org/10.1053/SRAO00300210
Zietman, and Shipley. "Randomized Trials in Loco-Regionally Confined Prostate Cancer: Past, Present, and Future." Seminars in radiation oncology vol. 3,3 (1993): 210-220. doi: https://doi.org/10.1053/SRAO00300210
Zietman AL, Shipley WU. Randomized Trials in Loco-Regionally Confined Prostate Cancer: Past, Present, and Future. Semin Radiat Oncol. 1993 Jul;3(3):210-220. doi: 10.1053/SRAO00300210. PMID: 10717072.
Copy Download .nbib Format: NLM
Anatomical Contributions to Hylobatid Taxonomy and Adaptation.

International journal of primatology

Zihlman AL, Mootnick AR, Underwood CE.
PMID: 21892236
Int J Primatol. 2011 Aug;32(4):865-877. doi: 10.1007/s10764-011-9506-y. Epub 2011 Mar 23.

Compared with the great apes, the small-bodied hylobatids were treated historically as a relatively uniform group with 2 genera, Hylobates and the larger-bodied Symphalangus. Four genera are now recognized, each with a different chromosome number: Hoolock (hoolock) (38), Hylobates...

Cite
Zihlman AL, Mootnick AR, Underwood CE. Anatomical Contributions to Hylobatid Taxonomy and Adaptation. Int J Primatol. 2011;32(4):865-877doi: 10.1007/s10764-011-9506-y.
Zihlman, A. L., Mootnick, A. R., & Underwood, C. E. (2011). Anatomical Contributions to Hylobatid Taxonomy and Adaptation. International journal of primatology, 32(4), 865-877. https://doi.org/10.1007/s10764-011-9506-y
Zihlman, Adrienne L, et al. "Anatomical Contributions to Hylobatid Taxonomy and Adaptation." International journal of primatology vol. 32,4 (2011): 865-877. doi: https://doi.org/10.1007/s10764-011-9506-y
Zihlman AL, Mootnick AR, Underwood CE. Anatomical Contributions to Hylobatid Taxonomy and Adaptation. Int J Primatol. 2011 Aug;32(4):865-877. doi: 10.1007/s10764-011-9506-y. Epub 2011 Mar 23. PMID: 21892236; PMCID: PMC3139862.
Copy Download .nbib Format: NLM
Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Tendulkar RD, Agrawal S, Gao T, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY, Liauw SL, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ.
PMID: 27528718
J Clin Oncol. 2016 Oct 20;34(30):3648-3654. doi: 10.1200/JCO.2016.67.9647.

PURPOSE: We aimed to update a previously published, multi-institutional nomogram of outcomes for salvage radiotherapy (SRT) following radical prostatectomy (RP) for prostate cancer, including patients treated in the contemporary era.METHODS: Individual data from node-negative patients with a detectable post-RP...

Cite
Tendulkar RD, Agrawal S, Gao T, et al. Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy. J Clin Oncol. 2016;34(30):3648-3654doi: 10.1200/JCO.2016.67.9647.
Tendulkar, R. D., Agrawal, S., Gao, T., Efstathiou, J. A., Pisansky, T. M., Michalski, J. M., Koontz, B. F., Hamstra, D. A., Feng, F. Y., Liauw, S. L., Abramowitz, M. C., Pollack, A., Anscher, M. S., Moghanaki, D., Den, R. B., Stephans, K. L., Zietman, A. L., Lee, W. R., Kattan, M. W., & Stephenson, A. J. (2016). Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34(30), 3648-3654. https://doi.org/10.1200/JCO.2016.67.9647
Tendulkar, Rahul D, et al. "Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34,30 (2016): 3648-3654. doi: https://doi.org/10.1200/JCO.2016.67.9647
Tendulkar RD, Agrawal S, Gao T, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY, Liauw SL, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ. Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy. J Clin Oncol. 2016 Oct 20;34(30):3648-3654. doi: 10.1200/JCO.2016.67.9647. PMID: 27528718.
Copy Download .nbib Format: NLM
Trajectories of (Bio)markers During the Development of Cognitive Frailty in the Doetinchem Cohort Study.

Frontiers in neurology

Rietman ML, Hulsegge G, Nooyens ACJ, Dollé MET, Picavet HSJ, Bakker SJL, Gansevoort RT, Spijkerman AMW, Verschuren WMM.
PMID: 31214102
Front Neurol. 2019 May 31;10:497. doi: 10.3389/fneur.2019.00497. eCollection 2019.

No abstract available.

Cite
Rietman ML, Hulsegge G, Nooyens ACJ, et al. Trajectories of (Bio)markers During the Development of Cognitive Frailty in the Doetinchem Cohort Study. Front Neurol. 2019;10:497doi: 10.3389/fneur.2019.00497.
Rietman, M. L., Hulsegge, G., Nooyens, A. C. J., Dollé, M. E. T., Picavet, H. S. J., Bakker, S. J. L., Gansevoort, R. T., Spijkerman, A. M. W., & Verschuren, W. M. M. (2019). Trajectories of (Bio)markers During the Development of Cognitive Frailty in the Doetinchem Cohort Study. Frontiers in neurology, 10497. https://doi.org/10.3389/fneur.2019.00497
Rietman, M Liset, et al. "Trajectories of (Bio)markers During the Development of Cognitive Frailty in the Doetinchem Cohort Study." Frontiers in neurology vol. 10 (2019): 497. doi: https://doi.org/10.3389/fneur.2019.00497
Rietman ML, Hulsegge G, Nooyens ACJ, Dollé MET, Picavet HSJ, Bakker SJL, Gansevoort RT, Spijkerman AMW, Verschuren WMM. Trajectories of (Bio)markers During the Development of Cognitive Frailty in the Doetinchem Cohort Study. Front Neurol. 2019 May 31;10:497. doi: 10.3389/fneur.2019.00497. eCollection 2019. PMID: 31214102; PMCID: PMC6555275.
Copy Download .nbib Format: NLM
Cystinuria: Review of a Life-long and Frustrating Disease.

The Yale journal of biology and medicine

Kowalczyk NS, Zisman AL.
PMID: 34970106
Yale J Biol Med. 2021 Dec 29;94(4):681-686. eCollection 2021 Dec.

Cystinuria, accounting for about 1-2% of kidney stones in adults, carries significant morbidity beginning at a young age [1]. Cystine stone formers have more stone events compared to other stone formers, as well as more surgical interventions, potentially contributing...

Cite
Kowalczyk NS, Zisman AL. Cystinuria: Review of a Life-long and Frustrating Disease. Yale J Biol Med. 2021;94(4):681-686
Kowalczyk, N. S., & Zisman, A. L. (2021). Cystinuria: Review of a Life-long and Frustrating Disease. The Yale journal of biology and medicine, 94(4), 681-686.
Kowalczyk, Nicholas S, and Zisman, Anna L. "Cystinuria: Review of a Life-long and Frustrating Disease." The Yale journal of biology and medicine vol. 94,4 (2021): 681-686.
Kowalczyk NS, Zisman AL. Cystinuria: Review of a Life-long and Frustrating Disease. Yale J Biol Med. 2021 Dec 29;94(4):681-686. eCollection 2021 Dec. PMID: 34970106; PMCID: PMC8686768.
Copy Download .nbib Format: NLM
Longitudinal Health Status and Quality of Life After Esophageal Atresia Repair.

Journal of pediatric gastroenterology and nutrition

Ten Kate CA, Rietman AB, van de Wijngaert Y, van Gils-Frijters A, Gischler SJ, Keyzer-Dekker CMG, Wijnen RMH, IJsselstijn H.
PMID: 34508046
J Pediatr Gastroenterol Nutr. 2021 Dec 01;73(6):695-702. doi: 10.1097/MPG.0000000000003293.

OBJECTIVES: To longitudinally evaluate self-reported and proxy-reported health status (HS) and quality of life (QoL) of school-aged children born with esophageal atresia (EA).METHODS: We obtained Pediatric Quality of Life Inventory (HS) and DUX-25 (QoL) questionnaires from children born with...

Cite
Ten Kate CA, Rietman AB, van de Wijngaert Y, et al. Longitudinal Health Status and Quality of Life After Esophageal Atresia Repair. J Pediatr Gastroenterol Nutr. 2021;73(6):695-702doi: 10.1097/MPG.0000000000003293.
Ten Kate, C. A., Rietman, A. B., van de Wijngaert, Y., van Gils-Frijters, A., Gischler, S. J., Keyzer-Dekker, C. M. G., Wijnen, R. M. H., & IJsselstijn, H. (2021). Longitudinal Health Status and Quality of Life After Esophageal Atresia Repair. Journal of pediatric gastroenterology and nutrition, 73(6), 695-702. https://doi.org/10.1097/MPG.0000000000003293
Ten Kate, Chantal A, et al. "Longitudinal Health Status and Quality of Life After Esophageal Atresia Repair." Journal of pediatric gastroenterology and nutrition vol. 73,6 (2021): 695-702. doi: https://doi.org/10.1097/MPG.0000000000003293
Ten Kate CA, Rietman AB, van de Wijngaert Y, van Gils-Frijters A, Gischler SJ, Keyzer-Dekker CMG, Wijnen RMH, IJsselstijn H. Longitudinal Health Status and Quality of Life After Esophageal Atresia Repair. J Pediatr Gastroenterol Nutr. 2021 Dec 01;73(6):695-702. doi: 10.1097/MPG.0000000000003293. PMID: 34508046.
Copy Download .nbib Format: NLM
In Reply to Royce et al.

Practical radiation oncology

Zietman AL.
PMID: 33941353
Pract Radiat Oncol. 2021 May-Jun;11(3):e353. doi: 10.1016/j.prro.2021.01.006.

No abstract available.

Cite
Zietman AL. In Reply to Royce et al. Pract Radiat Oncol. 2021;11(3):e353doi: 10.1016/j.prro.2021.01.006.
Zietman, A. L. (2021). In Reply to Royce et al. Practical radiation oncology, 11(3), e353. https://doi.org/10.1016/j.prro.2021.01.006
Zietman, Anthony L. "In Reply to Royce et al." Practical radiation oncology vol. 11,3 (2021): e353. doi: https://doi.org/10.1016/j.prro.2021.01.006
Zietman AL. In Reply to Royce et al. Pract Radiat Oncol. 2021 May-Jun;11(3):e353. doi: 10.1016/j.prro.2021.01.006. PMID: 33941353.
Copy Download .nbib Format: NLM
Racial Differences in Risk Factors for Kidney Stone Formation.

Clinical journal of the American Society of Nephrology : CJASN

Zisman AL, Coe FL, Cohen AJ, Riedinger CB, Worcester EM.
PMID: 32561654
Clin J Am Soc Nephrol. 2020 Aug 07;15(8):1166-1173. doi: 10.2215/CJN.12671019. Epub 2020 Jun 19.

BACKGROUND AND OBJECTIVES: Incidence of kidney stone disease is rising. It is not known whether mechanisms of stone formation differ across racial groups. Our objective was to identify differing lithogenic risk factors across racial groups in idiopathic nephrolithiasis.DESIGN, SETTING,...

Cite
Zisman AL, Coe FL, Cohen AJ, et al. Racial Differences in Risk Factors for Kidney Stone Formation. Clin J Am Soc Nephrol. 2020;15(8):1166-1173doi: 10.2215/CJN.12671019.
Zisman, A. L., Coe, F. L., Cohen, A. J., Riedinger, C. B., & Worcester, E. M. (2020). Racial Differences in Risk Factors for Kidney Stone Formation. Clinical journal of the American Society of Nephrology : CJASN, 15(8), 1166-1173. https://doi.org/10.2215/CJN.12671019
Zisman, Anna L, et al. "Racial Differences in Risk Factors for Kidney Stone Formation." Clinical journal of the American Society of Nephrology : CJASN vol. 15,8 (2020): 1166-1173. doi: https://doi.org/10.2215/CJN.12671019
Zisman AL, Coe FL, Cohen AJ, Riedinger CB, Worcester EM. Racial Differences in Risk Factors for Kidney Stone Formation. Clin J Am Soc Nephrol. 2020 Aug 07;15(8):1166-1173. doi: 10.2215/CJN.12671019. Epub 2020 Jun 19. PMID: 32561654; PMCID: PMC7409744.
Copy Download .nbib Format: NLM
DSM Nosology Changes in Neuropsychological Diagnoses through the Years: A Look at ADHD and Mild Neurocognitive Disorder.

Behavioral sciences (Basel, Switzerland)

Carlew AR, Zartman AL.
PMID: 28036066
Behav Sci (Basel). 2016 Dec 29;7(1). doi: 10.3390/bs7010001.

This article discusses the evolution of modern neuropsychology as a field and the concomitant changes in the Diagnostic and Statistical Manual of Mental Disorders (DSM). Themes in neuropsychology through the years will be highlighted alongside discussion of how neuropsychologists...

Cite
Carlew AR, Zartman AL. DSM Nosology Changes in Neuropsychological Diagnoses through the Years: A Look at ADHD and Mild Neurocognitive Disorder. Behav Sci (Basel). 2016;7(1)doi: 10.3390/bs7010001.
Carlew, A. R., & Zartman, A. L. (2016). DSM Nosology Changes in Neuropsychological Diagnoses through the Years: A Look at ADHD and Mild Neurocognitive Disorder. Behavioral sciences (Basel, Switzerland), 7(1), . https://doi.org/10.3390/bs7010001
Carlew, Anne R, and Zartman, Andrea L. "DSM Nosology Changes in Neuropsychological Diagnoses through the Years: A Look at ADHD and Mild Neurocognitive Disorder." Behavioral sciences (Basel, Switzerland) vol. 7,1 (2016). doi: https://doi.org/10.3390/bs7010001
Carlew AR, Zartman AL. DSM Nosology Changes in Neuropsychological Diagnoses through the Years: A Look at ADHD and Mild Neurocognitive Disorder. Behav Sci (Basel). 2016 Dec 29;7(1). doi: 10.3390/bs7010001. PMID: 28036066; PMCID: PMC5371745.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 66 entries